Disease details

Clinical trials : 3,340 / Drugs : 2,163 - (DrugBank : 383) / Drug target genes : 241 - Drug target pathways : 238

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00228228 (ClinicalTrials.gov)	May 2002	26/9/2005	TCV -01-002: T-Cell Vaccination in the Treatment of Probable Multiple Sclerosis	T-Cell Vaccination in the Treatment of Probable Multiple Sclerosis	Multiple Sclerosis	Biological: T cell vaccination	Sheba Medical Center	NULL	Recruiting	15 Years	50 Years	Both	80	Phase 3	Israel
2	NCT00220428 (ClinicalTrials.gov)	July 1998	14/9/2005	T-Cell Vaccination in Multiple Sclerosis (MS)	The Effect of T-Cell Vaccination in Multiple Sclerosis - Phase I/II Safety and Efficacy Trial	Multiple Sclerosis	Biological: T-Cell Vaccination	Sheba Medical Center	NULL	Recruiting	16 Years	60 Years	Both	20	Phase 1/Phase 2	Israel